MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1340.49

Change

-49.51 (-3.56)%

Market Cap

N/A

Volume

0.23M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-3.26 (-1.58%)

USD 148.68B
A Agilent Technologies Inc

-1.52 (-1.05%)

USD 43.23B
IQV IQVIA Holdings Inc

-1.17 (-0.56%)

USD 36.97B
LH Laboratory Corporation of Amer..

-1.19 (-0.48%)

USD 20.54B
DGX Quest Diagnostics Incorporated

+2.55 (+1.57%)

USD 16.93B
QGEN Qiagen NV

-1.26 (-3.05%)

USD 9.65B
CRL Charles River Laboratories

-3.90 (-2.38%)

USD 8.50B
VNRX Volitionrx Ltd

-0.02 (-3.33%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.02 (-3.57%)

USD 0.03B
TMO Thermo Fisher Scientific Inc

-18.61 (-3.26%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

+0.09 (+0.92%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

+0.01 (+0.92%)

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
EMOT First Trust Exchange-Trad.. 2.11 % 0.00 %

+0.20 (+0.92%)

USD 4.38M
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

-0.30 (0.92%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-1.52 (0.92%)

USD 6.25B
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.55% 92% A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.55% 85% B 87% B+
Trailing 12 Months  
Capital Gain 12.64% 85% B 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.64% 85% B 58% F
Trailing 5 Years  
Capital Gain 73.46% 92% A 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 73.46% 92% A 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 13.55% 77% C+ 72% C
Dividend Return 13.55% 69% C- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 29.06% 46% F 37% F
Risk Adjusted Return 46.63% 85% B 60% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.